Lytix Biopharma signs licensing agreement
Our member Lytix Biopharma has entered into a milestone agreement
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 276 entries.
Our member Lytix Biopharma has entered into a milestone agreement
Molecular diagnostics, clinical studies and exercise plans for cancer patients were three key topics raised in last week’s event.
Eivind changed his mind last minute to study medtech for cancer patients
EHiN is Norway’s largest conference on the digitalization of the health sector. Save the date 10-11 November 2020!